Dermatological Therapeutics Market, By Application (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, and Other Applications), By Drug Class (Anti-infectives, Corticosteroids, Anti-acne, Calcineurin Inhibitors, Retinoids and Other Drug Classes) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Some of the factors propelling market expansion include an increase in the elderly population, a growing awareness of the etiology and progression of dermatological diseases, and an increasing prevalence of these ailments. Additionally, dermatological therapy is expected to become more and more critical as the population ages. The likelihood of developing skin-related disorders rises with age due to various variables, including alterations in connective tissue, a decline in the hardness and flexibility of the skin, and a drop in sebaceous gland secretions. For example, the Globe Population Prospects 2019 report (2019) from the United Nations estimates that about 703 million people worldwide were 65 years of age or older in 2019. The number of elderly persons on the planet is predicted to reach 1.5 billion by 2050. The percentage of adults 65 and older in the world population increased from 6% in 1990 to 9% in 2019. Skin conditions have a substantial adverse influence on people's quality of life all over the world, leading to prejudice because of deformity and decreased productivity at work and other places. Skin changes may indicate the existence of more serious skin conditions that require medical attention. For example, the 2018 data sheet from the World Allergy Organization states that atopic dermatitis affects 5–30% of children and 1–10% of adults globally.